Zhang, Y.; Bissola, A.-L.; Treverton, J.; Hack, M.; Lychacz, M.; Kwok, S.; Arnold, A.; Nazy, I. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J. Clin. Med.2024, 13, 1012.
Zhang, Y.; Bissola, A.-L.; Treverton, J.; Hack, M.; Lychacz, M.; Kwok, S.; Arnold, A.; Nazy, I. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J. Clin. Med. 2024, 13, 1012.
Zhang, Y.; Bissola, A.-L.; Treverton, J.; Hack, M.; Lychacz, M.; Kwok, S.; Arnold, A.; Nazy, I. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J. Clin. Med.2024, 13, 1012.
Zhang, Y.; Bissola, A.-L.; Treverton, J.; Hack, M.; Lychacz, M.; Kwok, S.; Arnold, A.; Nazy, I. Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders. J. Clin. Med. 2024, 13, 1012.
Abstract
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but severe adverse event that was first observed during the global vaccination campaign against SARS-CoV-2 infection, specifically in those receiving adenoviral vector-based vaccines for Coronavirus disease 2019 (COVID-19). VITT develops 4 to 42 days post-vaccination and is characterized by the development of platelet-activating anti-platelet factor 4 (PF4) antibodies, leading to thrombocytopenia and thrombosis at unusual sites. The rise in awareness and subsequent prompt recognition of VITT was paramount in reducing mortality. Moreover, as vaccination campaigns around the world continue, a better understanding of VITT not only has important clinical implications but is also crucial for future vaccine development. In this review, we summarize the clinical features, pathophysiology, and incidence rates of VITT as well as highlight other anti-PF4 antibody-mediated disorders of growing clinical significance.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
